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Abstract 
Background: The Patient Reported Outcome Measurement Information System profile instruments include “high 
information” items drawn from large item banks following the application of modern psychometric criteria. The short-
est adult profile, PROMIS-29, looks set to replace existing short-form instruments in research and clinical practice. The 
objective of this study was to undertake the first psychometric evaluation of the Norwegian PROMIS-29, following a 
postal survey of a random sample of 12,790 Norwegians identified through the National Registry of the Norwegian 
Tax Administration. Confirmatory factor analysis was used to assess structural validity. Fit to the Rasch partial credit 
model and differential item functioning (DIF) were assessed in relation to age, gender, and education. PROMIS-29 
scores were compared to those for the EQ-5D-5L and the Self-assessed Comorbidity Questionnaire (SCQ), for pur-
poses of assessing validity based on a priori hypotheses.
Results: There were 3200 (25.9%) respondents with a mean age (SD) of 51 (20.7, range 18 to 97 years) and 55% were 
female. The PROMIS-29 showed satisfactory structural validity and acceptable fit to Rasch model including unidi-
mensionality, and measurement invariance across age and education levels. One pain interference item had uniform 
DIF for gender but splitting gave satisfactory fit. Domain reliability estimates ranged from 0.85 to 0.95. Correlations 
between PROMIS-29 domain, SCQ and EQ-5D scores were largely as expected, the largest being for scores assessing 
very similar aspects of health.
Conclusions: The Norwegian version of the PROMIS-29 is a reliable and valid generic self-reported measure of health 
in the Norwegian general population. The instrument is recommended for further application, but the analysis should 
be replicated and responsiveness to change assessed in future studies before it can be recommended for clinical and 
health services evaluation in Norway.
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Introduction
The US National Institutes of Health (NIH) Patient 
Reported Outcomes Measurement Information System 
(PROMIS®) is the most important development in the 
field of health status measurement, following the advent 
of short-form generic instruments over three decades ago 
[1]. PROMIS unifies measurement through standardized 
measures with broad applicability across health problems 
in clinical practice, research, and quality measurement 
[2]. The system builds on recent scientific advances 
including item response theory (IRT) and computer 
adaptive testing (CAT), resulting in higher precision 
and lower respondent burden respectively. Standardi-
zation, based on common metrics, allows for compari-
sons across domains, across health problems, and with 
the general population [2]. PROMIS measures are freely 
available and have widespread application internationally 
[3, 4].
PROMIS IRT-calibrated item banks assess aspects 
of physical, mental, and social health and include over 
300 measures for adults and children [4]. This approach 
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promotes flexibility in the selection of domains and items 
of relevance to specific health problems or populations 
[5]. PROMIS items within an item bank can be admin-
istered by short form fixed questionnaires (4–10 items) 
or CAT (4–12 items), with the former contributing to 
profiles.
The PROMIS-29 adult profile is a brief generic health 
measure comprising 29-items from the PROMIS domains 
of anxiety, depression, fatigue, pain (intensity and inter-
ference), physical function, sleep disturbance, satisfaction 
with participation in social roles (social participation) [2]. 
The PROMIS-29 has had rapid uptake since it became 
available in the last decade, including translation into 
over 40 languages [2], evaluation of measurement prop-
erties in different countries and populations [6–8], and 
application in research, including randomized con-
trolled trials [9–11]. The instrument has also been used 
in crosswalks or mapping to other widely used PROMs 
including the EuroQol EQ-5D [12]. The inclusion of an 
extra domain of cognitive function-abilities, or its impu-
tation using PROMIS-29 data, also makes it suitable for 
economic evaluation through the inclusion of values for 
health states in the form of PROPr [3, 13].
The present study describes the evaluation of the Nor-
wegian-language version of the PROMIS-29, following a 
postal survey of the general population for Norway. The 
measure was assessed for data quality, structural validity, 
fit of the seven domains to the IRT partial credit model, 
differential item functioning (DIF), internal consistency 
and convergent validity through comparisons with scores 
for the EQ-5D and a comorbidity questionnaire.
Methods
Data collection
This study was based on data from a national sample of 
Norwegians aged 18  years and over. Published Norwe-
gian surveys [14–18], informed the sample size and quota 
sampling for seven age groups and sex. The random sam-
ple of 12,790 adults aged 18 years and over, were selected 
from the Norwegian Tax Administration registry (Folk-
eregisteret). They were sent a postal questionnaire and 
reply-paid envelope addressed to the Norwegian Institute 
of Public Health on December 15, 2019. An accompany-
ing letter explained the study purpose and that respond-
ents would be included in a lottery of ten prizes each to 
the value of 1000 Euros.
The Regional Committee for Medical and Research 
Ethics stated that the study did not need ethical board 
approval and a Data Protection Impact Assessment was 
approved by the Institute on the 16th October 2019.
The questionnaire included the Norwegian version of 
the PROMIS-29 as distributed by the PROMIS Health 
Organization [19]. Translations of PROMIS measures 
follow FACIT universal methodology, an iterative pro-
cess of forward- and back-translation, expert review, har-
monization and cognitive interviewing [1]. Each domain 
comprises four items with five-point descriptive scales, 
except for pain intensity which has a 0–10 numerical rat-
ing scale. The sum of the item responses for each multi-
item domain are converted to T-scores where a score 
of 50 is the average for the US general population with 
a standard deviation of 10 [2, 19]. Higher scores repre-
sent more of a domain. Therefore, for physical function, 
higher scores represent better health whereas for anxiety, 
higher scores represent poorer health.
The questionnaire also included the Norwegian 
EQ-5D-5L which includes five dimensions (mobility, 
self-care, usual activities, pain/discomfort, and anxi-
ety/depression) with five levels [20]. Health states are 
transformed to a single index using a scoring algorithm 
derived from valuation tasks undertaken with general 
population samples. An algorithm is not yet available for 
Norway and hence, recommendations from the Norwe-
gian Medicines Agency [21] were followed, including the 
use of the UK value set [22] and mapping [23]. Scores for 
the EQ-5D index range from -0.59 to 1, where 1 is the 
best possible health state. In addition to the five dimen-
sions, the EQ VAS, assesses self-rated health on a vertical 
visual analogue scale, with endpoints labelled “Best imag-
inable health state” (100) and “Worst imaginable health 
state” (0). The presence of health problems was assessed 
by the Self-administered Comorbidity Questionnaire 
(SCQ), which lists thirteen medical conditions and up to 
three other non-specified medical problems [24]. Osteo- 
and rheumatoid arthritis are listed separately but scored 
as one. Respondents are asked if they have a condition, 
if they are receiving treatment for it, and if it limits their 
activities. All items use yes/no responses and are scored 
one for the former, giving a score range of 0 to 45, the 
latter equivalent to 15 conditions being present, treated, 
and limiting activities. The Norwegian version under-
went two independent forward-backwards translations 
in accordance with recommendations for PROMs trans-
lation [25]. Background questions included age, gender, 
and education level.
Statistical analysis
Statistical analysis followed an a priori analysis plan with 
explicit hypotheses. Missing data and floor and ceiling 
effects were assessed at the item and domain level. Con-
firmatory factor analysis (CFA) with robust weighted 
least squares (WLSMV) appropriate for categorical 
data [26, 27], was used to assess the structural valid-
ity of the PROMIS-29, or the extent to which the item 
scores adequately contribute to the seven domains [28]. 
Model fit was assessed by the Root Mean Square Error 
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Approximation (RMSEA, acceptable fit if < 0.06), the 
Comparative Fit Index (CFI, acceptable fit if > 0.95, poor 
fit if < 0.90, otherwise marginal) and the Tucker Lewis 
Index (TLI, acceptable fit if > 0.95, poor fit if < 0.90, other-
wise marginal) [27, 29].
The unidimensionality of each domain was tested using 
the partial credit model, which extends the Rasch model 
for polytomous items, and, hence has separable item 
and person parameters, sufficient statistics and conjoint 
additivity permitting item and person comparisons [30]. 
Overall and item fit statistics were used to assess whether 
items within the domains fitted the one-dimensional 
model. Item fit was assessed with the χ2 statistic, stand-
ardized residuals, which should be between ± 2.5, and 
item characteristic curves. Local independence, a fur-
ther assumption of Rasch models, was assessed through 
examination of the residual correlation matrix with coef-
ficients of ≥ 0.2 indicating redundancy among items [31, 
32].
Domain invariance was assessed through uniform and 
non-uniform differential item functioning (DIF) for age 
(6 categories), gender, and education level (3 categories); 
differences of ≥ 0.5 logits in item difficulties were consid-
ered meaningful [33, 34].
Internal consistency was assessed by Cronbach’s alpha 
[35] and the person separation index (PSI) [36]. These are 
similarly interpreted, but PSI uses the logit value (linear 
person estimate) or, proportion of error free variance of 
the distribution of person estimates relative to the sum 
of this variance and the error variance in these estimates. 
Reliability estimates of 0.7 and 0.90 deemed necessary for 
group and individual comparisons respectively [37].
Hypothesis testing was used to further assess the 
convergent validity of the PROMIS-29 domain scores 
through comparisons with those for the EQ-5D and 
SCQ. Inclusion of EQ-5D item data meant that Spear-
man correlation was used. Criteria for expected levels of 
correlation followed those used in a systematic review 
of generic PROMs [38]. First, correlations ≥ 0.60 were 
expected for scores assessing the same construct: anxi-
ety and depression and EQ-5D anxiety/depression; pain 
interference/intensity and EQ-5D pain/discomfort; phys-
ical function and EQ-5D mobility, usual activities; social 
participation and EQ-5D usual activities. Second, corre-
lations < 0.60 and ≥ 0.30 for instruments assessing largely 
related but dissimilar constructs: fatigue and EQ-5D 
anxiety/depression; pain interference and EQ-5D mobil-
ity, usual activities; physical function and EQ-5D self-
care, pain/discomfort; social participation and EQ-5D 
mobility. This level was also expected for correlations 
between all PROMIS-29 domain scores and those for 
the EQ-5D index and EQ VAS. Third, correlations < 0.50 
and ≥ 0.20 for scores assessing moderately related but 
dissimilar constructs: anxiety/depression and EQ-5D 
usual activities, pain/discomfort; fatigue and remaining 
EQ-5D scores; sleep disturbance and EQ-5D usual activi-
ties, pain/discomfort, anxiety/depression; pain intensity 
and EQ-5D mobility, usual activities, anxiety/depres-
sion; social participation, pain interference and EQ-5D 
self-care, anxiety/depression; social participation and 
EQ-5D pain/discomfort. Fourth, correlations < 0.30 were 
expected for scores assessing weakly related or unrelated 
constructs: anxiety/depression and EQ-5D mobility, self-
care; pain intensity and EQ-5D self-care; physical func-
tion and EQ-5D anxiety/depression; sleep disturbance 
and EQ-5D mobility, self-care.
Different studies using a variety of approaches to 
assessing multimorbidity, including simple counts, have 
found that higher levels of multimorbidity are associated 
with poorer health [39]. One third of SCQ scores com-
prise activity limitations and correlations of up to 0.4 
have been found with SF-36 scores [24]. The great major-
ity of SCQ items relate to somatic health problems, and 
hence, correlations in the range < 0.5 and ≥ 0.20 were 
expected for PROMIS-29 domains of physical func-
tion, social participation, pain interference/intensity. 
Lower correlations < 0.3 were expected for the remain-
ing domains. EQ-5D domains comprise single items, 
and hence, compared to the PROMIS-29, lower correla-
tions in the same range were expected with SCQ scores. 
Slightly higher correlations were expected for the EQ-5D 
index and EQ VAS scores which assess health more 
generally.
Statistical analyses were undertaken using RUMM2020 
v4.1 (Rumm Laboratory, Perth, Western Australia), 
Mplus version 7 (Muthe’n & Muthe’n, Los Angeles, CA) 




Of the 12,790 questionnaires mailed, 426 were returned 
as incorrectly addressed, and one person had died. Of the 
remainder, 3,200 (25.9%) returned a questionnaire that 
was at least partly completed. The mean age (SD) was 
51 (20.7) and ages ranged from 18 to 97 years (Table 1). 
There were approximately 10% more female respond-
ents than men, and 247 to 698 respondents across seven 
age categories; the lowest number of respondents was 
for 80  years and above and the highest was for those 
18–29  years of age. Compared to general population 
data available from Statistics Norway from the time of 
the data collection [40] survey respondents were also 
over-represented for the youngest and oldest age groups, 
highest education level, and married/domestic partner 
(Table 1).
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Distribution of scores
Levels of missing data for the PROMIS-29 ranged from 
0.3 to 3.4% for items relating to sleep and anxiety respec-
tively (Table  2). The four anxiety items had the highest 
levels of missing data for any domain. Floor or ceiling 
effects, indicative of the best possible health, were appar-
ent and over 70% for ten items. For the PROMIS-29 
domains, 71% of respondents had the best possible physi-
cal function, the other domains ranging from 7.5 to 54.2% 
for sleep disturbance and depression respectively.
Psychometric evaluation
Figure 1 shows the results of the CFA and the fit indices, 
which indicate that the seven-factor model met criteria 
for model fit (RMSEA = 0.059 [0.057–0.060], CFI = 0.987, 
TLI = 0.985). Correlations between the seven domains 
ranged from 0.36 to 0.89.
The p values for the chi-square statistics in Table  3 
show that the PROMIS-29 items and domains fit the 
Rasch unidimensional model. Moreover, the results 
were highly consistent with no disordered thresholds for 
any item, and correlations between item residuals did 
not suggest any lack of local independence. Additional 
file  1  includes the item characteristic curves for these 
items. There was no evidence of age or education DIF 
and only the pain interference item, “How much did pain 
interfere with your household chores?”, was affected by 
uniform DIF relating to gender (> 0.5 logits), indicating 
that compared to males, females gave responses showing 
more severe impact across the scale. This item was split 
to create gender-specific versions of the same item which 
gave satisfactory model fit.
The correlations with the EQ-5D were largely consist-
ent with a priori hypotheses. Correlations ≥ 0.60 were 
found for PROMIS domain scores and those for the 
EQ-5D assessing the same construct, the highest being 
for those relating to pain. More moderate correlations 
for domain and EQ-5D scores assessing largely related 
but dissimilar constructs were found in the range 0.47 to 
0.55. Correlations with the EQ-5D index scores were con-
siderably higher than the expected upper level of 0.6 for 
the two PROMIS domains relating to pain interference 
and pain intensity. They were also slightly higher than 
this level for physical function and social participation.
Table  4 also shows that PROMIS-29 domain and 
EQ-5D scores had statistically significant associations 
with those for the SCQ, the highest being for domains 
relating most to physical health which were largely above 
the expected range of < 0.50 and ≥ 0.20, and particularly 
for pain domains. Correlations for the EQ-5D item scores 
were, as expected, slightly lower, except for anxiety/
depression. The correlation for the EQ-5D index scores 
were higher than those for EQ-5D items and PROMIS 
domains. The EQ-VAS correlation was lower than 
expected, and below that for the PROMIS-29 domains 
that relate most to physical health. Overall, 53 (83%) of 
the 64 correlations for the PROMIS-29 were within the 
hypothesized range.
Discussion
The PROMIS-29 performed satisfactorily in relation 
to measurement criteria widely recommended in the 
evaluation of PROMs including classical and modern 
psychometric methods [28]. Levels of missing data were 
low across the 29 items, but many items show high ceil-
ing effects denoting the highest possible levels of health, 
which meant that the domain scores for all but the sleep 
disturbance domain, were highly skewed. This follows 
previous findings for general populations from France, 
Germany and the UK [7, 41]. Short-form instruments 
Table 1 Respondent characteristics (n = 3200) compared to the 
general population
a Missing data: 11, 30, 16, 20, 166 cases for gender, age, education, marital status, 
and health problems respectively






Female 1755 55.0 49.8
Male 1434 45.0 50.2
Age, years
 18–29 698 22.0 19.6
 30–39 391 12.3 17.1
 40–49 374 11.8 17.0
 50–59 461 14.5 16.6
 60–69 487 15.4 13.8
 70–79 512 16.2 10.3
  >  = 80 247 7.8 5.6
Education
 Basic (≤ 10 years) 296 9.3 23.4
 Secondary (11–13 years) 1240 38.9 39.7
 Degree 777 24.4 25.2
 Postgraduate 871 27.4 11.7
Marital status
 Never married (Single) 695 21.9 28.7
 Domestic partner (living as a couple) 637 20.0 16.1
 Married/civil partnership 1493 46.9 39.6
 Divorced/separated 170 5.3 10.6
 Widowed 185 5.8 5.0
Health  problemsb
 None 1088 35.9 –
 One 882 29.1 –
 Two or more 1064 35.1 –
Page 5 of 11Garratt et al. J Patient Rep Outcomes            (2021) 5:86  
such as the PROMIS-29, include the most important 
health domains and items of general relevance across sick 
and healthy populations, and hence, skewed data towards 
positive health was not unexpected in this population. 
Highly skewed PROMs data is common for general pop-
ulation samples [14–16]. In a comparison of data from 
Germany, Poland, South Korea, and USA, the 5L version 
of the EQ-5D reported here, was found to have ceiling 
effects in the range of 48 to 97% and 35 to 61% for item 
and index scores respectively [42]. Skewed data might be 
also expected in younger age groups with more minor 
health problems. Given the potential supplementary 
information that they offer, additional PROMIS short-
forms, item banks and/or condition-specific instruments 
Table 2 Descriptives for PROMIS-29 items and domains, and reliability (Cronbach’s alpha)
a Item score range from 1 to 5. Domains are T-scores where a score of 50 is the average for the US general population with a standard deviation of 10. Higher scores for 
domains and items represent more of a domain, for example, higher levels of physical functioning or anxiety
b Numerical rating scale from 0 to 10; 0 is lowest and 10 the greatest pain intensity
Scale/item Missing % Mean (SD)a Floor % Ceiling % Cronbach’s 
alpha
Physical Function 2.7 52.61 (7.41) 0.6 70.6 0.93
 Are you able to do chores such as vacuuming or yard work 1.6 4.57 (0.90) 2.3 75.7
 Are you able to go up and down stairs at a normal pace 1.8 4.63 (0.85) 1.9 79.4
 Are you able to go for a walk of at least 15 min 1.8 4.79 (0.75) 1.8 87.6
 Are you able to run errands and shop 2.2 4.77 (0.70) 1.4 87.4
Anxiety 3.9 47.94 (8.41) 45.9 0.1 0.90
 I felt fearful 1.9 1.41 (0.75) 71.7 0.2
 I found it hard to focus on anything other than my anxiety 3.4 1.30 (0.68) 80.0 0.5
 My worries overwhelmed me 2.8 1.52 (0.85) 66.9 0.5
 I felt uneasy 2.9 1.76 (0.93) 50.7 0.7
Depression 2.8 47.37 (7.99) 54.2 0.3 0.91
 I felt worthless 0.7 1.45 (0.82) 71.5 0.7
 I felt helpless 0.8 1.46 (0.83) 70.9 0.8
 I felt depressed 1.3 1.54 (0.86) 65.6 0.5
 I felt hopeless 1.8 1.33 (0.75) 79.6 0.7
Fatigue 2.7 44.69 (9.78) 31.9 0.6 0.95
 I feel fatigued 0.7 1.87 (1.00) 44.5 2.5
 I have trouble starting things because I am tired 1.7 1.83 (0.96) 45.0 1.7
 How run-down did you feel on average 1.6 1.80 (0.94) 46.3 1.4
 How fatigued were you on average 1.8 1.81 (0.94) 45.5 1.2
Sleep Disturbance 2.2 47.40 (8.11) 7.5 0.8 0.85
 My sleep quality was… 0.3 2.41 (1.00) 17.6 3.1
 My sleep was refreshing 1.1 2.60 (1.04) 13.0 5.3
 I had a problem with my sleep 1.1 2.04 (1.03) 35.9 2.6
 I had difficulty falling asleep 1.3 1.94 (1.08) 44.5 3.4
Ability to participate in social roles and activities 1.8 55.82 (8.46) 0.8 40.6 0.93
 I have trouble doing all of my regular leisure activities with others 0.5 4.28 (1.03) 2.5 57.7
 I have trouble doing all of the family activities that I want to do 1.2 4.34 (0.98) 1.8 60.4
 I have trouble doing all of my usual work (include work at home) 0.7 4.26 (1.02) 2.3 56.4
 I have trouble doing all of the activities with friends that I want to do 1.0 4.12 (1.08) 2.7 49.7
Pain interference 3.0 48.83 (8.44) 50.8 1.1 0.96
 How much did pain interfere with your day to day activities 1.8 1.73 (0.97) 53.6 1.9
 How much did pain interfere with work around the home 2.6 1.59 (0.94) 63.6 1.8
 How much did pain interfere with your ability to participate in social activities 2.1 1.50 (0.94) 71.1 2.2
 How much did pain interfere with your household chores 2.3 1.55 (0.93) 66.4 2.2
Pain intensityb
 How would you rate your pain on average 1.9 1.95 (2.12) 31.5 0.1 -
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Correlations F1 F2 F3 F4 F5 F6 F7
F1 Physical function 1
F2 Anxiety 0.41 1
F3 Depression 0.56 0.89 1
F4 Fatigue 0.55 0.57 0.63 1 Fit indices
F5 Sleep disturbance 0.36 0.41 0.45 0.50 1 CFI = 0.987
F6 Social participation 0.75 0.49 0.58 0.65 0.41 1 TLI = 0.985
F7 Pain interference 0.75 0.38 0.47 0.58 0.42 0.68 1 RMSEA = 0.059 [0.057-0.060]
Path diagrams (with standardized coefficients) for the seven-factor model with fit indices using confirmatory factor analysis (robust 
weighted least squares [WLSMV] estimator). Ellipses represent unobserved latent factors, rectangles represent observed variables, single-
headed arrows represent the effect of one variable on another (factor loading) and double-headed arrows represent covariance between pairs 
of variables. ε: measurement error df: degree of freedom. CFI: Comparative Fit Index. TLI: Tucker Lewis Index. RMSEA: Root Mean 
Square Error Approximation. The residual variances are not estimated when a WLSMV estimator is used.
Fig. 1 Confirmatory factor analysis
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should be considered for application alongside short-
form generic instruments.
CFA showed that the Norwegian PROMIS-29 had good 
evidence for structural validity including the presence 
of the seven domains. Rasch analysis further confirmed 
unidimensionality of the seven domains which had 
acceptable levels of reliability, with all domains close to, 
or meeting the more stringent criterion of 0.9 [37]. This 
follows the findings of the developers and similar testing 
in general populations for other countries [7, 41]. The 
instrument was not affected by DIF for age and education 
levels but as was found previously [41], females and males 
were found to respond differently to one of the items 
within the pain interference domain. At 0.5 logits, this 
is considered a large effect [34]. DIF has greater impli-
cations for domains that comprise few items, including 
those within the PROMIS-29. It is recommended that 
the domain of pain interference is analysed separately for 
Table 3 Rasch analysis for the seven domains of the Norwegian PROMIS-29
a Overall fit p value for chi-square, where a non-significance (p > 0.05) indicates fit to the Rasch model. Person separation index is an estimate of reliability or the 
proportion of error free variance of the distribution of person estimates relative to the sum of this variance and the error variance in these estimates
b Location is the item position on the latent scale or level of health assessed. Fit residuals are the difference between the observed and expected scores for the item, a 
non-significant (p > 0.05) chi-square indicating fit to the Rasch model
Domain/item (Overall fit p value, person separation index)a Locationb Fit residual Chi-square P value
Physical function (0.86, 0.92)
 Are you able to do chores such as vacuuming, housework, or light gardening − 0.66 0.29 2.38 0.88
 Are you able to go up and down stairs normal pace − 0.30 1.46 2.84 0.83
 Are you able to go for a walk of at least 15 min 0.35 − 2.46 6.33 0.39
 Are you able to run errands and shop 0.61 − 1.51 5.19 0.52
Anxiety (0.96, 0.91)
 I felt fearful 0.72 2.98 2.28 0.94
 I found it hard to focus on anything other than my anxiety 0.64 − 3.50 7.17 0.41
 My worries overwhelmed me − 0.26 − 0.53 5.09 0.65
 I felt uneasy − 1.10 − 3.84 1.54 0.98
Depression (0.97, 0.89)
 I felt worthless − 0.06 0.63 1.92 0.93
 I felt helpless − 0.16 1.92 2.25 0.90
 I felt depressed − 0.17 1.18 1.27 0.97
 I felt hopeless 0.39 − 3.43 7.16 0.31
Fatigue (0.16, 0.93)
 I felt fatigued − 0.43 − 2.76 1.45 0.98
 I have trouble starting things because I am tired − 0.06 6.11 14.90 0.04
 How run-down did you feel on average 0.21 − 4.20 3.71 0.81
 How fatigued were you on average 0.28 − 10.71 15.48 0.03
Sleep disturbance (0.64, 0.85)
 My sleep quality was… − 0.23 − 5.43 9.31 0.41
 My sleep was refreshing − 0.75 8.52 8.57 0.48
 I had a problem with my sleep 0.48 − 8.07 10.38 0.32
 I had difficulty falling asleep 0.50 0.15 4.11 0.90
Ability to participate in social roles and activities (0.64, 0.85)
 I have trouble doing all of my regular leisure activities and exercise 0.03 0.35 2.52 0.96
 I have trouble doing all of my family activities that I want to do 0.39 − 1.71 4.15 0.84
 I have trouble doing all of my usual work (including working at home) 0.05 3.87 0.72 1.00
 I have trouble doing all of the activities with friends that I want to do − 0.47 − 1.97 3.68 0.88
Pain interference (0.02, 0.95)
 How much did pain interfere with your day to day activities − 0.70 − 0.13 10.55 0.16
 How much did pain interfere with work around the home 0.13 − 9.04 13.37 0.06
 How much did pain interfere with your ability to participate in social activities 0.34 2.52 11.57 0.12
 How much did pain interfere with your household chores 0.24 − 3.96 9.43 0.22
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gender [41]. Several of the fit residuals were outside of 
the ± 2.5 range but this was a large sample size which can 
make them unreliable [43].
The great majority of the correlations for the conver-
gent validity of the PROMIS-29 were as hypothesized 
and met the criterion of 75% [28]. The remainder were 
all higher than expected. The EQ-5D is the most widely 
tested and applied generic PROM suitable for use in eco-
nomic evaluation [20, 44], and hence, comparisons by 
means of expected correlations with the PROMIS-29, 
increase our understanding of the latter in terms of its 
validity as a short-form generic health profile. Given their 
general focus, criteria for expected levels of correlation 
followed those used in a systematic review [38] and psy-
chometric testing of generic PROMs [44]. The criteria, in 
terms of the range of correlations, are overlapping which 
takes consideration of different approaches to assessing 
health constructs and their operationalization, through 
items and scaling. For example, PROMIS-29 uses multi-
item scales with several domain scores, whereas the 
EQ-5D uses single items that form an index based on 
preferences or values for health states obtained from the 
general population [20].
Domain scores that assess the same or very similar 
constructs had correlations exceeding the expected level 
of 0.6. The levels of correlation were highest for those 
assessing aspects of pain. The PROMIS-29 domain of 
pain interference assesses the effect of pain on daily 
activities, and arguably has the greatest overlap with 
the any of the EQ-5D dimensions. The EQ-5D assesses 
anxiety and depression through a single item, whereas 
PROMIS-29 has two separate domains which are highly 
correlated, but as this and other studies have found, are 
distinct [7, 41]. Previous studies have also found accept-
able levels of correlation between PROMIS-29 scores and 
those for other legacy instruments including the SF-36 
[41, 45]. The consistent association with the SCQ scores 
provides further empirical support for the convergent 
validity of the PROMIS-29 [41]. Furthermore, it supports 
its potential use as a measure of quality of care for people 
with multimorbidity and for the development of systems 
for identifying individuals at risk of deterioration [46, 47].
Strengths and limitations
The study was comparable in scope and size to existing 
European studies that have assessed the measurement 
properties of the PROMIS-29 in the general population 
[7, 41]. This secured more than an adequate sample size 
for the application of CFA and the Rasch partial credit 
model. The latter has been widely applied in the field 
of health measurement and while the graded response 
model has been more widely used for PROMIS measures 
[2], the Rasch partial credit model has had considerable 
application in Europe, including the PROMIS-29 [41]. 
It is encouraging that the PROMIS-29 domains demon-
strate adequate fit to both models.
Table 4 Spearman correlation coefficients between PROMIS-29, EQ-5D-5L and SCQ scores (n = 2936)
Listwise correlations all statistically significant: p < 0.001. Negative coefficients were removed for purposes of presentation
EQ-5D-5L SCQ




EQ-5D index EQ VAS
EQ-5D-5L
 Self-care 0.52
 Usual activities 0.62 0.51
 Pain/discomfort 0.46 0.32 0.49
 Anxiety/depression 0.21 0.18 0.33 0.31
 EQ-5D index 0.61 0.61 0.64 0.88 0.58
 EQ VAS 0.45 0.41 0.52 0.52 0.38 0.60
SCQ 0.43 0.27 0.44 0.59 0.29 0.62 0.49
PROMIS-29
 Physical function 0.67 0.47 0.64 0.54 0.29 0.63 0.55 0.55
 Anxiety 0.19 0.16 0.31 0.30 0.73 0.47 0.38 0.27
 Depression 0.31 0.26 0.42 0.35 0.71 0.53 0.44 0.33
 Fatigue 0.34 0.26 0.48 0.46 0.53 0.57 0.57 0.38
 Sleep disturbance 0.24 0.19 0.33 0.39 0.41 0.45 0.42 0.34
 Social participation 0.48 0.37 0.60 0.50 0.47 0.63 0.56 0.50
 Pain interference 0.52 0.35 0.55 0.73 0.34 0.73 0.55 0.61
 Pain intensity 0.46 0.31 0.48 0.79 0.35 0.76 0.54 0.61
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Previous studies have included the SF-36, an estab-
lish generic health profile, for purposes of assessing the 
validity of the PROMIS-29 [41, 45]. The current study 
included the EQ-5D, which is the most widely tested 
and used PROM suitable for use in economic evaluation 
[20, 44]. In common with these studies, this was a cross-
sectional design, and hence, responsiveness to changes in 
health was not assessed. The survey was conducted three 
months before the COVID-19 pandemic in Norway and a 
one-year follow-up survey that included the PROMIS-29, 
was implemented to assess the impact of the pandemic 
on the health of the Norwegian general population. It 
is anticipated that PROMIS measures including the 
PROMIS-29, will have increasing use in Norway. The 
PROMIS-57 has evidence for measurement properties in 
a smaller Norwegian general population sample recruited 
through mainstream and social media [48] and is being 
used in a long-term follow-up of COVID-19 outpatients 
[49]. Several item banks and short forms have been trans-
lated for children with national applications including the 
Norwegian Pandemic Register [50] and Child Hip Regis-
ter [51].
National data from Statistics Norway shows that the 
sample cannot be considered fully representative of the 
general population. It is uncertain whether a more rep-
resentative sample would have influenced the findings of 
the psychometric analyses, but there was no evidence for 
DIF across age groups and education levels. The response 
rate of 26% would have increased had a reminder been 
used, but this would have proved costly with over 9,000 
non-respondents.
Conclusions
In conclusion, the Norwegian-language PROMIS-29 has 
evidence for acceptable measurement properties includ-
ing reliability and validity, in a large sample of the Nor-
wegian general population. Subject to further testing 
including responsiveness to change, it may be suitable for 
applications where a short-form profile measure of health 
is required that offers more detailed information than the 
EQ-5D. However, this study only assessed a limited range 
of measurement properties in the general population. 
Further testing is recommended in patient populations 
along with an evaluation of responsiveness to changes in 
health.
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